Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.54)
# 263
Out of 5,148 analysts
563
Total ratings
52.31%
Success rate
24.02%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $16.06 | +130.39% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $15.30 | +30.72% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.21 | +126.24% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $513.82 | -2.69% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $188.05 | +3.16% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.81 | +53.65% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.11 | +350.10% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $90.10 | -33.41% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $22.81 | +40.29% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $486.03 | +13.16% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $146.32 | -17.99% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $6.53 | +22.51% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $6.01 | -66.72% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $30.94 | +13.12% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.40 | +48.94% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $36.69 | -4.61% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.52 | +153.62% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $62.90 | +19.24% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $16.15 | +135.29% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $13.91 | +79.73% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $21.00 | +52.38% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.63 | +247.62% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $23.25 | -31.18% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $13.39 | +79.24% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.88 | +316.67% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $132.61 | -71.34% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $132.38 | +26.91% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $3.30 | +233.33% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.50 | +300.00% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $13.85 | +58.84% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $20.55 | -2.65% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.58 | +659.49% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.76 | +125.69% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $9.07 | +21.28% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.97 | +285.26% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.05 | +1,328.57% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $23.88 | +46.57% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $8.35 | +798.20% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $3.17 | +120.82% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.89 | +429.10% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.62 | +24,152.22% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $13.93 | +330.73% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.62 | +166.90% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.89 | +4,419.26% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $16.06
Upside: +130.39%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $15.30
Upside: +30.72%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.21
Upside: +126.24%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $513.82
Upside: -2.69%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $188.05
Upside: +3.16%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.81
Upside: +53.65%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.11
Upside: +350.10%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $90.10
Upside: -33.41%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $22.81
Upside: +40.29%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $486.03
Upside: +13.16%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $146.32
Upside: -17.99%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $6.53
Upside: +22.51%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $6.01
Upside: -66.72%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $30.94
Upside: +13.12%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.40
Upside: +48.94%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $36.69
Upside: -4.61%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.52
Upside: +153.62%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $62.90
Upside: +19.24%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $16.15
Upside: +135.29%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $13.91
Upside: +79.73%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $21.00
Upside: +52.38%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.63
Upside: +247.62%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $23.25
Upside: -31.18%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $13.39
Upside: +79.24%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.88
Upside: +316.67%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $132.61
Upside: -71.34%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $132.38
Upside: +26.91%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $3.30
Upside: +233.33%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $2.50
Upside: +300.00%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $13.85
Upside: +58.84%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $20.55
Upside: -2.65%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.58
Upside: +659.49%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.76
Upside: +125.69%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $9.07
Upside: +21.28%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.97
Upside: +285.26%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.05
Upside: +1,328.57%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $23.88
Upside: +46.57%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.35
Upside: +798.20%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $3.17
Upside: +120.82%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.89
Upside: +429.10%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.62
Upside: +24,152.22%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $13.93
Upside: +330.73%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.62
Upside: +166.90%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.89
Upside: +4,419.26%